List of Tables
Table 1. Active Pharmaceutical Ingredient Market Segments
Table 2. Ranking of Global Top Active Pharmaceutical Ingredient Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Active Pharmaceutical Ingredient Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Synthetic API
Table 5. Major Manufacturers of Biotech API
Table 6. Major Manufacturers of Other
Table 7. Global Active Pharmaceutical Ingredient Market Size Growth Rate by Application 2020-2026 (K MT)
Table 8. Global Active Pharmaceutical Ingredient Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 9. Global Active Pharmaceutical Ingredient Sales by Regions 2015-2020 (K MT)
Table 10. Global Active Pharmaceutical Ingredient Sales Market Share by Regions (2015-2020)
Table 11. Global Active Pharmaceutical Ingredient Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Active Pharmaceutical Ingredient Sales by Manufacturers (2015-2020) (K MT)
Table 13. Global Active Pharmaceutical Ingredient Sales Share by Manufacturers (2015-2020)
Table 14. Global Active Pharmaceutical Ingredient Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Active Pharmaceutical Ingredient by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Active Pharmaceutical Ingredient as of 2019)
Table 16. Active Pharmaceutical Ingredient Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Active Pharmaceutical Ingredient Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Active Pharmaceutical Ingredient Price (2015-2020) (USD/MT)
Table 19. Active Pharmaceutical Ingredient Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Active Pharmaceutical Ingredient Product Type
Table 21. Date of International Manufacturers Enter into Active Pharmaceutical Ingredient Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Active Pharmaceutical Ingredient Sales by Type (2015-2020) (K MT)
Table 24. Global Active Pharmaceutical Ingredient Sales Share by Type (2015-2020)
Table 25. Global Active Pharmaceutical Ingredient Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Active Pharmaceutical Ingredient Revenue Share by Type (2015-2020)
Table 27. Active Pharmaceutical Ingredient Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 28. Global Active Pharmaceutical Ingredient Sales by Application (2015-2020) (K MT)
Table 29. Global Active Pharmaceutical Ingredient Sales Share by Application (2015-2020)
Table 30. North America Active Pharmaceutical Ingredient Sales by Country (2015-2020) (K MT)
Table 31. North America Active Pharmaceutical Ingredient Sales Market Share by Country (2015-2020)
Table 32. North America Active Pharmaceutical Ingredient Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Active Pharmaceutical Ingredient Revenue Market Share by Country (2015-2020)
Table 34. North America Active Pharmaceutical Ingredient Sales by Type (2015-2020) (K MT)
Table 35. North America Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
Table 36. North America Active Pharmaceutical Ingredient Sales by Application (2015-2020) (K MT)
Table 37. North America Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
Table 38. Europe Active Pharmaceutical Ingredient Sales by Country (2015-2020) (K MT)
Table 39. Europe Active Pharmaceutical Ingredient Sales Market Share by Country (2015-2020)
Table 40. Europe Active Pharmaceutical Ingredient Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Active Pharmaceutical Ingredient Revenue Market Share by Country (2015-2020)
Table 42. Europe Active Pharmaceutical Ingredient Sales by Type (2015-2020) (K MT)
Table 43. Europe Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
Table 44. Europe Active Pharmaceutical Ingredient Sales by Application (2015-2020) (K MT)
Table 45. Europe Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Active Pharmaceutical Ingredient Sales by Region (2015-2020) (K MT)
Table 47. Asia Pacific Active Pharmaceutical Ingredient Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Active Pharmaceutical Ingredient Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Active Pharmaceutical Ingredient Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Active Pharmaceutical Ingredient Sales by Type (2015-2020) (K MT)
Table 51. Asia Pacific Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Active Pharmaceutical Ingredient Sales by Application (2015-2020) (K MT)
Table 53. Asia Pacific Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
Table 54. Latin America Active Pharmaceutical Ingredient Sales by Country (2015-2020) (K MT)
Table 55. Latin America Active Pharmaceutical Ingredient Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Active Pharmaceutical Ingredient Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Active Pharmaceutical Ingredient Revenue Market Share by Country (2015-2020)
Table 58. Latin America Active Pharmaceutical Ingredient Sales by Type (2015-2020) (K MT)
Table 59. Latin America Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
Table 60. Latin America Active Pharmaceutical Ingredient Sales by Application (2015-2020) (K MT)
Table 61. Latin America Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Active Pharmaceutical Ingredient Sales by Country (2015-2020) (K MT)
Table 63. Middle East and Africa Active Pharmaceutical Ingredient Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Active Pharmaceutical Ingredient Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Active Pharmaceutical Ingredient Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Active Pharmaceutical Ingredient Sales by Type (2015-2020) (K MT)
Table 67. Middle East and Africa Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Active Pharmaceutical Ingredient Sales by Application (2015-2020) (K MT)
Table 69. Middle East and Africa Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
Table 70. Teva Corporation Information
Table 71. Teva Description and Major Businesses
Table 72. Teva Active Pharmaceutical Ingredient Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 73. Teva Product
Table 74. Teva Recent Development
Table 75. Novartis Corporation Information
Table 76. Novartis Description and Major Businesses
Table 77. Novartis Active Pharmaceutical Ingredient Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Novartis Product
Table 79. Novartis Recent Development
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Major Businesses
Table 82. Pfizer Active Pharmaceutical Ingredient Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Pfizer Product
Table 84. Pfizer Recent Development
Table 85. Johnson & Johnson Corporation Information
Table 86. Johnson & Johnson Description and Major Businesses
Table 87. Johnson & Johnson Active Pharmaceutical Ingredient Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Johnson & Johnson Product
Table 89. Johnson & Johnson Recent Development
Table 90. Mylan Corporation Information
Table 91. Mylan Description and Major Businesses
Table 92. Mylan Active Pharmaceutical Ingredient Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Mylan Product
Table 94. Mylan Recent Development
Table 95. North China Pharmaceutical Group Corporation Information
Table 96. North China Pharmaceutical Group Description and Major Businesses
Table 97. North China Pharmaceutical Group Active Pharmaceutical Ingredient Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. North China Pharmaceutical Group Product
Table 99. North China Pharmaceutical Group Recent Development
Table 100. Dr. Reddy’s Laboratories Corporation Information
Table 101. Dr. Reddy’s Laboratories Description and Major Businesses
Table 102. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Dr. Reddy’s Laboratories Product
Table 104. Dr. Reddy’s Laboratories Recent Development
Table 105. Roche Corporation Information
Table 106. Roche Description and Major Businesses
Table 107. Roche Active Pharmaceutical Ingredient Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Roche Product
Table 109. Roche Recent Development
Table 110. Aurobindo pharma Corporation Information
Table 111. Aurobindo pharma Description and Major Businesses
Table 112. Aurobindo pharma Active Pharmaceutical Ingredient Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. Aurobindo pharma Product
Table 114. Aurobindo pharma Recent Development
Table 115. Sun Pharmaceutical Industries Corporation Information
Table 116. Sun Pharmaceutical Industries Description and Major Businesses
Table 117. Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 118. Sun Pharmaceutical Industries Product
Table 119. Sun Pharmaceutical Industries Recent Development
Table 120. Boehringer Ingelheim GmbH Corporation Information
Table 121. Boehringer Ingelheim GmbH Description and Major Businesses
Table 122. Boehringer Ingelheim GmbH Active Pharmaceutical Ingredient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Boehringer Ingelheim GmbH Product
Table 124. Boehringer Ingelheim GmbH Recent Development
Table 125. Bayer Corporation Information
Table 126. Bayer Description and Major Businesses
Table 127. Bayer Active Pharmaceutical Ingredient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Bayer Product
Table 129. Bayer Recent Development
Table 130. BASF Corporation Information
Table 131. BASF Description and Major Businesses
Table 132. BASF Active Pharmaceutical Ingredient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. BASF Product
Table 134. BASF Recent Development
Table 135. DSM Corporation Information
Table 136. DSM Description and Major Businesses
Table 137. DSM Active Pharmaceutical Ingredient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. DSM Product
Table 139. DSM Recent Development
Table 140. Zhejiang Medicine Corporation Information
Table 141. Zhejiang Medicine Description and Major Businesses
Table 142. Zhejiang Medicine Active Pharmaceutical Ingredient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 143. Zhejiang Medicine Product
Table 144. Zhejiang Medicine Recent Development
Table 145. Biocon Corporation Information
Table 146. Biocon Description and Major Businesses
Table 147. Biocon Active Pharmaceutical Ingredient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 148. Biocon Product
Table 149. Biocon Recent Development
Table 150. Johnson Matthey Corporation Information
Table 151. Johnson Matthey Description and Major Businesses
Table 152. Johnson Matthey Active Pharmaceutical Ingredient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 153. Johnson Matthey Product
Table 154. Johnson Matthey Recent Development
Table 155. Hisun Pharmacy Corporation Information
Table 156. Hisun Pharmacy Description and Major Businesses
Table 157. Hisun Pharmacy Active Pharmaceutical Ingredient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 158. Hisun Pharmacy Product
Table 159. Hisun Pharmacy Recent Development
Table 160. Cambrex Corporation Information
Table 161. Cambrex Description and Major Businesses
Table 162. Cambrex Active Pharmaceutical Ingredient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 163. Cambrex Product
Table 164. Cambrex Recent Development
Table 165. Shandong Xinhua Pharmaceutical Corporation Information
Table 166. Shandong Xinhua Pharmaceutical Description and Major Businesses
Table 167. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 168. Shandong Xinhua Pharmaceutical Product
Table 169. Shandong Xinhua Pharmaceutical Recent Development
Table 170. Lonza group Corporation Information
Table 171. Lonza group Description and Major Businesses
Table 172. Lonza group Active Pharmaceutical Ingredient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 173. Lonza group Product
Table 174. Lonza group Recent Development
Table 175. Huahai Pharmaceutical Corporation Information
Table 176. Huahai Pharmaceutical Description and Major Businesses
Table 177. Huahai Pharmaceutical Active Pharmaceutical Ingredient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 178. Huahai Pharmaceutical Product
Table 179. Huahai Pharmaceutical Recent Development
Table 180. Haerbin Pharmaceutical Group Corporation Information
Table 181. Haerbin Pharmaceutical Group Description and Major Businesses
Table 182. Haerbin Pharmaceutical Group Active Pharmaceutical Ingredient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 183. Haerbin Pharmaceutical Group Product
Table 184. Haerbin Pharmaceutical Group Recent Development
Table 185. Cipla Corporation Information
Table 186. Cipla Description and Major Businesses
Table 187. Cipla Active Pharmaceutical Ingredient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 188. Cipla Product
Table 189. Cipla Recent Development
Table 190. Tian Yao Corporation Information
Table 191. Tian Yao Description and Major Businesses
Table 192. Tian Yao Active Pharmaceutical Ingredient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 193. Tian Yao Product
Table 194. Tian Yao Recent Development
Table 195. Lupin Corporation Information
Table 196. Lupin Description and Major Businesses
Table 197. Lupin Active Pharmaceutical Ingredient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 198. Lupin Product
Table 199. Lupin Recent Development
Table 200. North East Pharmaceutical Corporation Information
Table 201. North East Pharmaceutical Description and Major Businesses
Table 202. North East Pharmaceutical Active Pharmaceutical Ingredient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 203. North East Pharmaceutical Product
Table 204. North East Pharmaceutical Recent Development
Table 205. Albemarle Corporation Information
Table 206. Albemarle Description and Major Businesses
Table 207. Albemarle Active Pharmaceutical Ingredient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 208. Albemarle Product
Table 209. Albemarle Recent Development
Table 210. Shandong Lukang Pharmaceutical Corporation Information
Table 211. Shandong Lukang Pharmaceutical Description and Major Businesses
Table 212. Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 213. Shandong Lukang Pharmaceutical Product
Table 214. Shandong Lukang Pharmaceutical Recent Development
Table 215. Jiangsu Hengrui Medicine Corporation Information
Table 216. Jiangsu Hengrui Medicine Description and Major Businesses
Table 217. Jiangsu Hengrui Medicine Active Pharmaceutical Ingredient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 218. Jiangsu Hengrui Medicine Product
Table 219. Jiangsu Hengrui Medicine Recent Development
Table 220. Global Active Pharmaceutical Ingredient Sales Forecast by Regions (2021-2026) (K MT)
Table 221. Global Active Pharmaceutical Ingredient Sales Market Share Forecast by Regions (2021-2026)
Table 222. Global Active Pharmaceutical Ingredient Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 223. Global Active Pharmaceutical Ingredient Revenue Market Share Forecast by Regions (2021-2026)
Table 224. North America: Active Pharmaceutical Ingredient Sales Forecast by Country (2021-2026) (K MT)
Table 225. North America: Active Pharmaceutical Ingredient Revenue Forecast by Country (2021-2026) (US$ Million)
Table 226. Europe: Active Pharmaceutical Ingredient Sales Forecast by Country (2021-2026) (K MT)
Table 227. Europe: Active Pharmaceutical Ingredient Revenue Forecast by Country (2021-2026) (US$ Million)
Table 228. Asia Pacific: Active Pharmaceutical Ingredient Sales Forecast by Region (2021-2026) (K MT)
Table 229. Asia Pacific: Active Pharmaceutical Ingredient Revenue Forecast by Region (2021-2026) (US$ Million)
Table 230. Latin America: Active Pharmaceutical Ingredient Sales Forecast by Country (2021-2026) (K MT)
Table 231. Latin America: Active Pharmaceutical Ingredient Revenue Forecast by Country (2021-2026) (US$ Million)
Table 232. Middle East and Africa: Active Pharmaceutical Ingredient Sales Forecast by Country (2021-2026) (K MT)
Table 233. Middle East and Africa: Active Pharmaceutical Ingredient Revenue Forecast by Country (2021-2026) (US$ Million)
Table 234. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 235. Key Challenges
Table 236. Market Risks
Table 237. Main Points Interviewed from Key Active Pharmaceutical Ingredient Players
Table 238. Active Pharmaceutical Ingredient Customers List
Table 239. Active Pharmaceutical Ingredient Distributors List
Table 240. Research Programs/Design for This Report
Table 241. Key Data Information from Secondary Sources
Table 242. Key Data Information from Primary Sources
List of Figures
Figure 1. Active Pharmaceutical Ingredient Product Picture
Figure 2. Global Active Pharmaceutical Ingredient Sales Market Share by Type in 2020 & 2026
Figure 3. Synthetic API Product Picture
Figure 4. Biotech API Product Picture
Figure 5. Other Product Picture
Figure 6. Global Active Pharmaceutical Ingredient Sales Market Share by Application in 2020 & 2026
Figure 7. Chemical
Figure 8. Deodorant
Figure 9. Dailylife
Figure 10. Active Pharmaceutical Ingredient Report Years Considered
Figure 11. Global Active Pharmaceutical Ingredient Market Size 2015-2026 (US$ Million)
Figure 12. Global Active Pharmaceutical Ingredient Sales 2015-2026 (K MT)
Figure 13. Global Active Pharmaceutical Ingredient Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Active Pharmaceutical Ingredient Sales Market Share by Region (2015-2020)
Figure 15. Global Active Pharmaceutical Ingredient Sales Market Share by Region in 2019
Figure 16. Global Active Pharmaceutical Ingredient Revenue Market Share by Region (2015-2020)
Figure 17. Global Active Pharmaceutical Ingredient Revenue Market Share by Region in 2019
Figure 18. Global Active Pharmaceutical Ingredient Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Active Pharmaceutical Ingredient Revenue in 2019
Figure 20. Active Pharmaceutical Ingredient Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
Figure 22. Global Active Pharmaceutical Ingredient Sales Market Share by Type in 2019
Figure 23. Global Active Pharmaceutical Ingredient Revenue Market Share by Type (2015-2020)
Figure 24. Global Active Pharmaceutical Ingredient Revenue Market Share by Type in 2019
Figure 25. Global Active Pharmaceutical Ingredient Market Share by Price Range (2015-2020)
Figure 26. Global Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
Figure 27. Global Active Pharmaceutical Ingredient Sales Market Share by Application in 2019
Figure 28. Global Active Pharmaceutical Ingredient Revenue Market Share by Application (2015-2020)
Figure 29. Global Active Pharmaceutical Ingredient Revenue Market Share by Application in 2019
Figure 30. North America Active Pharmaceutical Ingredient Sales Growth Rate 2015-2020 (K MT)
Figure 31. North America Active Pharmaceutical Ingredient Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Active Pharmaceutical Ingredient Sales Market Share by Country in 2019
Figure 33. North America Active Pharmaceutical Ingredient Revenue Market Share by Country in 2019
Figure 34. U.S. Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.S. Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 37. Canada Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Active Pharmaceutical Ingredient Market Share by Type in 2019
Figure 39. North America Active Pharmaceutical Ingredient Market Share by Application in 2019
Figure 40. Europe Active Pharmaceutical Ingredient Sales Growth Rate 2015-2020 (K MT)
Figure 41. Europe Active Pharmaceutical Ingredient Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Active Pharmaceutical Ingredient Sales Market Share by Country in 2019
Figure 43. Europe Active Pharmaceutical Ingredient Revenue Market Share by Country in 2019
Figure 44. Germany Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 45. Germany Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 47. France Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.K. Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 51. Italy Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 53. Russia Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Active Pharmaceutical Ingredient Market Share by Type in 2019
Figure 55. Europe Active Pharmaceutical Ingredient Market Share by Application in 2019
Figure 56. Asia Pacific Active Pharmaceutical Ingredient Sales Growth Rate 2015-2020 (K MT)
Figure 57. Asia Pacific Active Pharmaceutical Ingredient Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Active Pharmaceutical Ingredient Sales Market Share by Region in 2019
Figure 59. Asia Pacific Active Pharmaceutical Ingredient Revenue Market Share by Region in 2019
Figure 60. China Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 61. China Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 63. Japan Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 65. South Korea Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 67. India Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 69. Australia Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 71. Taiwan Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 73. Indonesia Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 75. Thailand Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 77. Malaysia Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 79. Philippines Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 81. Vietnam Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Active Pharmaceutical Ingredient Market Share by Type in 2019
Figure 83. Asia Pacific Active Pharmaceutical Ingredient Market Share by Application in 2019
Figure 84. Latin America Active Pharmaceutical Ingredient Sales Growth Rate 2015-2020 (K MT)
Figure 85. Latin America Active Pharmaceutical Ingredient Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Active Pharmaceutical Ingredient Sales Market Share by Country in 2019
Figure 87. Latin America Active Pharmaceutical Ingredient Revenue Market Share by Country in 2019
Figure 88. Mexico Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 89. Mexico Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 91. Brazil Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 93. Argentina Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Active Pharmaceutical Ingredient Market Share by Type in 2019
Figure 95. Latin America Active Pharmaceutical Ingredient Market Share by Application in 2019
Figure 96. Middle East and Africa Active Pharmaceutical Ingredient Sales Growth Rate 2015-2020 (K MT)
Figure 97. Middle East and Africa Active Pharmaceutical Ingredient Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Active Pharmaceutical Ingredient Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Active Pharmaceutical Ingredient Revenue Market Share by Country in 2019
Figure 100. Turkey Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 101. Turkey Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 103. Saudi Arabia Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 105. U.A.E Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Active Pharmaceutical Ingredient Market Share by Type in 2019
Figure 107. Middle East and Africa Active Pharmaceutical Ingredient Market Share by Application in 2019
Figure 108. North America Active Pharmaceutical Ingredient Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 109. North America Active Pharmaceutical Ingredient Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Active Pharmaceutical Ingredient Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 111. Europe Active Pharmaceutical Ingredient Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Active Pharmaceutical Ingredient Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. Asia Pacific Active Pharmaceutical Ingredient Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Active Pharmaceutical Ingredient Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Latin America Active Pharmaceu
